Scientific and Medical Equipment House Company (4014.SR)
SAR 51.1
(0.2%)
SAR 51.1
(0.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -140.63 Million | 124.01 Million | -84.72 Million | 117.31 Million | 162.82 Million | -108.56 Million |
| Net Income | 52.95 Million | 17.56 Million | 77.52 Million | 74.76 Million | 70.66 Million | 68.07 Million |
| Depreciation & Amortization | 22.64 Million | 13.5 Million | 12.81 Million | 9.41 Million | 6.85 Million | 4.34 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -258.96 Million | 28.86 Million | -188.33 Million | 6.2 Million | 54.58 Million | -197.33 Million |
| Other non-cash items | 42.73 Million | 64.07 Million | 13.27 Million | 26.93 Million | 30.72 Million | -176.63 Million |
| Investing Cash Flow | -14.92 Million | -17.57 Million | 4.66 Million | -22.52 Million | -39.01 Million | -2.86 Million |
| Investments in PPE | -14.87 Million | -17.81 Million | -7.44 Million | -22.96 Million | -10.53 Million | -2.96 Million |
| Acquisitions | 1.54 Million | 165.96 Thousand | -716.39 Thousand | 238.26 Thousand | 2.03 Million | 199.43 Thousand |
| Investment purchases | - | - | 955.9 Thousand | - | -28.75 Million | - |
| Sales/Maturities of investments | - | - | 11.67 Million | - | -1.96 Million | - |
| Other Investing Activities | -1.59 Million | 70.52 Thousand | 201.45 Thousand | 200.96 Thousand | 193.75 Thousand | -2.86 Million |
| Financing Cash Flow | 117.95 Million | -97.2 Million | 36.74 Million | -80.39 Million | -109.73 Million | 106.18 Million |
| Debt repayment | -916.27 Million | -68.01 Million | -71.36 Million | -46.04 Million | -57.41 Million | -116.12 Million |
| Dividends payments | - | -20 Million | -30 Million | - | -20 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 131.34 Million | -9.18 Million | 138.1 Million | -34.35 Million | -32.32 Million | 106.18 Million |
| Accounts receivables | -223.47 Million | 75.14 Million | -222.15 Million | 46.61 Million | 30.26 Million | -137.15 Million |
| Accounts payables | -18.76 Million | 8.34 Million | 6.88 Million | -788.94 Thousand | -7.34 Million | -7.77 Million |
| Inventory | -10.36 Million | -4.58 Million | -12.14 Million | -58.15 Million | 4.84 Million | 12.66 Million |
| Other working capital | -6.36 Million | -50.04 Million | 39.08 Million | 18.52 Million | 26.82 Million | -65.07 Million |
| Cash at beginning of period | 54.55 Million | 45.32 Million | 88.63 Million | 74.25 Million | 57.52 Million | 62.75 Million |
| Cash at end of period | 16.94 Million | 54.55 Million | 45.32 Million | 88.63 Million | 74.25 Million | 57.5 Million |
| Capital Expenditure | -14.87 Million | -17.81 Million | -7.44 Million | -22.96 Million | -10.53 Million | -2.96 Million |
| Effect of forex changes on cash | - | - | 5.00 | - | 2.65 Million | - |
| Net cash flow / Change in cash | -37.61 Million | 9.23 Million | -43.31 Million | 14.38 Million | 16.72 Million | -5.25 Million |
| Free Cash Flow | -155.51 Million | 106.2 Million | -92.17 Million | 94.34 Million | 152.29 Million | -111.52 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.66 Million | 8.76 Million | 52.95 Million | 18.48 Million | 20.35 Million | 4.65 Million |
| Depreciation & Amortization | 5.06 Million | 5.29 Million | 22.64 Million | 5.43 Million | 6.33 Million | 5.8 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.8 Million | 76.21 Million | -258.96 Million | -74.81 Million | -98.77 Million | -38.94 Million |
| Other non-cash items | 12.17 Million | -35.37 Million | 42.73 Million | 38.34 Million | -3.4 Million | 6.98 Million |
| Investing Cash Flow | -556.08 Thousand | 702.02 Thousand | -14.92 Million | -2.58 Million | -1.13 Million | -4.08 Million |
| Investments in PPE | -1.34 Million | -610.37 Thousand | -14.87 Million | -1.79 Million | -1.7 Million | -4.16 Million |
| Acquisitions | 498.65 Thousand | 1.31 Million | 1.54 Million | 810.35 Thousand | 571.26 Thousand | 78.87 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 294.44 Thousand | 702 Thousand | -1.59 Million | -1.59 Million | 571.26 Thousand | 78.87 Thousand |
| Financing Cash Flow | -62.33 Million | -43.95 Million | 117.95 Million | 8.73 Million | 29.41 Million | 32.74 Million |
| Debt repayment | -60.48 Million | -40.09 Million | -916.27 Million | -293.58 Million | -295.67 Million | -235.65 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.84 Million | -50.65 Million | 131.34 Million | 12.96 Million | 325.08 Million | 268.39 Million |
| Accounts receivables | 5.95 Million | 56.15 Million | -223.47 Million | -52.87 Million | -84.12 Million | -48.16 Million |
| Accounts payables | -12.8 Million | 7.41 Million | -18.76 Million | -17.86 Million | -10.61 Million | 9.44 Million |
| Inventory | 6.7 Million | -6.71 Million | -10.36 Million | 6.47 Million | -346.02 Thousand | -13.32 Million |
| Other working capital | 2.95 Million | 19.36 Million | -6.36 Million | -10.54 Million | -3.68 Million | 13.1 Million |
| Cash at beginning of period | 74.86 Million | 16.94 Million | 54.55 Million | 23.34 Million | 70.56 Million | 63.4 Million |
| Cash at end of period | 29.4 Million | 74.86 Million | 16.94 Million | 16.94 Million | 23.34 Million | 70.56 Million |
| Capital Expenditure | -1.34 Million | -610.37 Thousand | -14.87 Million | -1.79 Million | -1.7 Million | -4.16 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -45.46 Million | 57.92 Million | -37.61 Million | -6.4 Million | -47.21 Million | 7.16 Million |
| Free Cash Flow | 16.07 Million | 100.56 Million | -155.51 Million | -14.34 Million | -77.2 Million | -25.66 Million |
CHTH
KR
3592
2293
002861
BEP